Related Experiment Videos
Chromosomal and genetic abnormalities in myeloma
1Institute of Haematology and Centenary Institute of Cancer Medicine and Cell Biology, Royal Prince Alfred Hospital, Sydney, Australia.
Clinical and Laboratory Haematology
|October 3, 2002
Summary
Multiple myeloma (MM) involves numerous genetic abnormalities, including chromosome 13q deletions and immunoglobulin heavy chain (IgH) translocations. Further research is clarifying the role of these molecular changes in MM pathogenesis and prognosis.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Multiple myeloma (MM) is a plasma cell malignancy characterized by significant chromosomal abnormalities.
- Key genetic alterations include 13q deletions and translocations at the immunoglobulin heavy chain (IgH) locus.
Purpose of the Study:
- To review common molecular abnormalities in multiple myeloma.
- To discuss the evidence for their pathogenic role in MM.
Main Methods:
- Review of existing literature on genetic abnormalities in multiple myeloma.
- Analysis of molecular cytogenetic techniques for detecting these changes.
Main Results:
- Frequent genetic abnormalities in MM include 13q deletions and IgH translocations.
- Other aberrations involve numerical changes, non-Ig gene translocations, and oncogene mutations (e.g., N-ras).
- 13q deletions are consistently linked to poor prognosis, while the role of other changes is under investigation.
Conclusions:
- Refined molecular cytogenetic techniques enhance the detection of MM-associated abnormalities.
- The precise impact of most genetic alterations on MM pathogenesis and prognosis requires further clarification.